SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BALDI, Eleonora
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.698
EU - Europa 444
AS - Asia 263
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.696
CN - Cina 177
IT - Italia 132
UA - Ucraina 94
GB - Regno Unito 65
TR - Turchia 64
DE - Germania 57
SE - Svezia 30
FI - Finlandia 27
BE - Belgio 17
HK - Hong Kong 10
FR - Francia 7
AT - Austria 5
AU - Australia 4
IR - Iran 4
PL - Polonia 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IQ - Iraq 2
NL - Olanda 2
CA - Canada 1
ES - Italia 1
HN - Honduras 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
RO - Romania 1
Totale 2.412
Salva come PNG Salva come JPEG
Città #
Woodbridge 236
Fairfield 182
Chandler 161
Ann Arbor 131
Ashburn 130
Houston 128
Jacksonville 110
Ferrara 65
Wilmington 58
Cambridge 57
Seattle 53
Nanjing 41
Izmir 40
New York 38
Milan 36
Princeton 32
Beijing 31
Dearborn 29
Boardman 22
Shanghai 22
Addison 21
Brussels 17
San Diego 15
Nanchang 14
Bremen 12
Shenyang 12
Hong Kong 10
Jiaxing 9
Norwalk 8
Jinan 7
Los Angeles 7
Auburn Hills 6
Changsha 6
Hebei 6
Tianjin 6
Bologna 5
Des Moines 5
Redwood City 5
San Mateo 5
Vienna 5
Washington 5
Guangzhou 4
Ningbo 4
Warsaw 4
Augusta 3
Dong Ket 3
Indiana 3
Kunming 3
Leawood 3
London 3
Mountain View 3
Redmond 3
Sant'elena 3
Udine 3
Ardabil 2
Chicago 2
Hangzhou 2
Harringay 2
Lanzhou 2
Naples 2
Orange 2
Philadelphia 2
Poggio Renatico 2
Tappahannock 2
Ankara 1
Baotou 1
Changchun 1
Cormeilles-en-Parisis 1
Dublin 1
Exeter 1
Ferrara di Monte Baldo 1
Hanoi 1
Harbin 1
Hefei 1
Helsinki 1
Hounslow 1
Hull 1
Kilburn 1
Madrid 1
Mezzolombardo 1
Odesa 1
Pescara 1
Quzhou 1
Rome 1
San Pedro Sula 1
Schiphol 1
Shaoxing 1
Simi Valley 1
Tokyo 1
Toronto 1
Utrecht 1
Villa Guardia 1
Yellow Springs 1
Zhengzhou 1
Totale 1.880
Salva come PNG Salva come JPEG
Nome #
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 139
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 129
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 126
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 120
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 119
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 115
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 114
Epidemiological health and social study on multiple sclerosis in the Ferrara province 110
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 105
null 104
null 90
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 87
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 83
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 75
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 74
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 73
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 67
null 66
null 66
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 62
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 61
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 60
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 59
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 56
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 56
null 45
MMP-9 isoforms in serum of Multiple Sclerosis patients 40
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 30
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 26
Smaller optic nerve diameters and reduced flow velocity of ophthalmic artery suggest a history of optic neuritides: Transorbital Ultrasonography and Doppler Ultrasound in multiple sclerosis 23
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 22
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 21
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 10
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study 9
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study 8
Pediatric recurrent acute necrotizing encephalomyelitis, RANBP2 genotype and Sars-CoV-2 infection: Diagnosis, pathogenesis and targeted treatments from a case study 8
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS 8
Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. 5
Totale 2.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019214 0 0 0 0 0 0 0 0 0 59 52 103
2019/2020495 82 18 22 57 27 59 60 56 39 50 16 9
2020/2021298 21 22 11 31 16 33 8 31 14 41 47 23
2021/2022290 8 36 23 5 15 11 14 14 13 25 24 102
2022/2023382 34 44 9 58 56 41 27 38 33 5 22 15
2023/2024227 23 16 11 5 38 52 19 34 17 12 0 0
Totale 2.471